中科微至科技股份有限公司 2023 年年度股东大会会议资料 证券代码：688211 证券简称：中科微至 中科微至科技股份有限公司 2023 年年度股东大会 会议资料 2024 年 5 月 中科微至科技股份有限公司 2023 年年度股东大会会议资料 中科微至科技股份有限公司 2023 年年度股东大会会议资料 中科微至科技股份有限公司 2023 年年度股东大会会议须知 为维护全体股东的合法权益，保障中科微至科技股份有限公司（以下简称"公 司"）股东在本次股东大会期间依法行使权利，根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 中国证券监督管理委员会《上市公司股东大会规则》和《中科微至科技股份有限 公司章程》（以下简称"《公司章程》"）、《中科微至科技股份有限公司股东大 会议事规则》等有关规定，特制定本须知： 一、公司负责本次股东大会的议程安排和会务工作，为确认出席大会的股东 或其代理人或其他出席者的出席资格，公司工作人员将对出席会议者的身份进行 核对，请被核对者给予配合。 二、出席会议的股东及股东代理人须在会议召开前半小时到达会议现场办理 签到手续。 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 中科微至科技股份有限公司（以下简称"公司"）于2024年4月20日召开了第 二届董事会第九次会议、第二届监事会第七次会议，审议通过了《关于<中科微 至科技股份有限公司2024年限制性股票激励计划（草案）>及其摘要的议案》及 《关于制定<中科微至科技股份有限公司2024年限制性股票激励计划实施考核管 理办法>的议案》。具体内容详见公司于2024年4月23日在上海证券交易所网站 （www.sse.com.cn）披露的《中科微至科技股份有限公司2024年限制性股票激励 计划（草案）》（以下简称"《激励计划（草案）》"）、《中科微至科技股份有 限公司2024年限制性股票激励计划实施考核管理办法》等文件。 证券代码：688211 证券简称：中科微至 公告编号：2024-023 中科微至科技股份有限公司 关于 2024 年限制性股票激励计划 内幕信息知情人买卖公司股票情况的自查报告 根据《上市公司股权激励管理办法》等相关法律、法规及规范性文件规定， 针对公司2024年限制性股票激励计划（ ...

Financial Performance - The company's operating revenue for Q1 2024 was ¥344,577,070.46, representing an increase of 18.35% compared to the same period last year[5] - The net profit attributable to shareholders was a loss of ¥41,764,489.21, a decrease of 231.89% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥69,400,898.92, a decrease of 463.18% compared to the previous year[5] - The basic and diluted earnings per share were both -¥0.33, a decrease of 237.50% compared to the same period last year[5] - In Q1 2024, the company reported a net loss of CNY 41,764,493.93, compared to a net profit of CNY 31,665,379.43 in Q1 2023, representing a significant decline[17] - Operating profit for Q1 2024 was CNY -53,627,384.71, a decrease from CNY 32,884,490.00 in the same period last year[17] - The total comprehensive income for Q1 2024 was CNY -42,569,976.39, compared to CNY 31,722,359.29 in Q1 2023[18] Cash Flow - The net cash flow from operating activities was ¥93,684,717.58, down 58.61% year-on-year due to increased cash payments for goods and services[5] - Cash flow from operating activities was CNY 93,684,717.58, a decrease of 58.6% compared to CNY 226,327,468.86 in Q1 2023[20] - The company experienced a cash inflow of CNY 1,420,919,675.40 from investment activities, an increase from CNY 1,202,057,359.22 in Q1 2023[21] - Cash and cash equivalents at the end of Q1 2024 amounted to CNY 465,065,742.13, an increase from CNY 311,462,627.63 at the end of Q1 2023[21] - The net cash flow from investment activities was -$7.53 million, an improvement from -$161.11 million in the previous year[31] - Cash and cash equivalents at the end of the period increased to $426.87 million, up from $286.35 million year-over-year[31] - The cash inflow from investment activities totaled $1.39 billion, an increase from $1.20 billion year-over-year[31] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,554,694,588.31, a decrease of 2.14% from the end of the previous year[6] - Total assets as of March 31, 2024, were RMB 6,554,694,588.31, down from RMB 6,698,323,995.36 at the end of 2023, a decrease of 2.1%[15] - The company's equity attributable to shareholders was RMB 3,595,432,882.46, down from RMB 3,650,888,635.44, a decrease of 1.5%[15] - Total liabilities decreased to RMB 2,959,261,865.44 from RMB 3,047,435,514.79, reflecting a reduction of 2.9%[15] - The total liabilities decreased to ¥2,446,937,604.40 in Q1 2024, down from ¥2,538,370,284.93 in Q4 2023, representing a decline of about 3.6%[24] Research and Development - Research and development expenses totaled ¥40,206,161.95, accounting for 11.67% of operating revenue, a decrease of 5.94 percentage points from the previous year[6] - The company incurred research and development expenses of CNY 40,206,161.95, down from CNY 51,273,769.04 in Q1 2023, indicating a reduction in R&D investment[17] - Research and development expenses for Q1 2024 were ¥36,193,689.15, down from ¥47,409,560.61 in Q1 2023, showing a decrease of about 23.6%[27] Shareholder Information - The total number of common shareholders at the end of the reporting period was 12,549[10] - The company has not reported any changes in the participation of major shareholders in margin trading or securities lending activities[12] Inventory and Receivables - Accounts receivable decreased to RMB 507,609,343.98 from RMB 628,574,662.64, indicating a reduction of 19.2%[14] - The company's inventory decreased to ¥1,841,887,940.82 in Q1 2024, down from ¥1,909,385,903.95 at the end of 2023, indicating a reduction of approximately 3.5%[23] - The company reported a decrease in accounts receivable to ¥471,572,684.76 in Q1 2024, down from ¥619,725,141.61 at the end of 2023, indicating a reduction of about 24%[23]

中科微至科技股份有限公司 自 2023 年 1 月 1 日 至 2023 年 12 月 31 日止年度财务报表 the state of the .. the state of the subject of the subject of the station of the station of the subject of the station of the stati KPMG Huazhen LLP 8th Floor, KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 +86 (10) 8518 5111 Fax Internet kpmg.com/cn 毕马威华振会计师事务所 (特殊普通合伙) 中国北京 东长安街1号 东方广场毕马威大楼8层 邮政编码:100738 电话 +86(10)8508 5000 传真 +86 (10) 8518 5111 网址 kpmg.com/cn 审计报告 =马威华振审字第 2406738 号 中科微至科技股份有限公司全体 ...

Financial Performance - The company's operating revenue for 2023 was CNY 1,957,396,951, a decrease of 15.44% compared to CNY 2,314,895,871 in 2022[22]. - The net profit attributable to shareholders for 2023 was CNY 20,852,700.49, a significant recovery from a loss of CNY 118,719,653.61 in 2022[22]. - The net cash flow from operating activities improved to CNY 622,485,339.64, compared to a negative cash flow of CNY 37,440,908.80 in 2022[22]. - The total assets increased by 20.62% to CNY 6,698,323,995.36 at the end of 2023, up from CNY 5,553,468,596.01 in 2022[22]. - The company's gross profit margin for its main business was 22.25%, an increase of 7.80 percentage points year-on-year[23]. - The basic earnings per share for 2023 was CNY 0.16, recovering from a loss of CNY 0.90 in 2022[23]. - The weighted average return on equity increased to 0.58%, up 3.73 percentage points from -3.15% in 2022[23]. - The company's net profit attributable to shareholders increased by CNY 139.57 million year-on-year, with a significant reduction in non-recurring gains and losses by CNY 6.21 million[24]. - The company reported a net profit attributable to shareholders of CNY 20.85 million in 2023, an increase of CNY 13,957.24 million year-on-year[127]. Dividend Distribution - The company plans to distribute cash dividends of RMB 0.79 per 10 shares, totaling RMB 10,083,344.73, which accounts for 48.36% of the net profit attributable to shareholders for 2023[5]. - The total share capital as of March 31, 2024, is 131,608,698 shares, with 3,971,423 shares in the repurchase account excluded from the profit distribution calculation[5]. - The company does not plan to increase capital reserves or issue bonus shares for the 2023 fiscal year[5]. Audit and Compliance - The company has confirmed the accuracy and completeness of the financial report by its management team[5]. - The company has received a standard unqualified audit report from KPMG Huazhen[5]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[8]. - There are no violations of decision-making procedures regarding external guarantees[8]. Research and Development - Research and development expenses accounted for 8.57% of operating revenue, a slight decrease from 8.93% in 2022[23]. - Total R&D investment for the year was approximately ¥167.84 million, a decrease of 18.79% compared to the previous year's ¥206.68 million[78]. - The R&D team includes 1 PhD, 159 master's graduates, and 366 bachelor's graduates, indicating a strong educational background[100]. - The company is focusing on product maturity and optimization, which has led to improved gross margins and cost efficiencies across its main business segments[135]. Market Expansion and Strategy - The company has expanded its customer base to include major domestic clients and has established sales centers in Asia, America, Europe, and Africa[38]. - The company plans to enhance its product matrix and expand into new fields and overseas markets, focusing on integrated solutions for conveying, sorting, and warehousing[173]. - The company aims to expand its overseas market presence in regions such as Southeast Asia, Russia, and Europe, having already established branches in multiple countries including Singapore, the USA, and Germany[183]. Technology and Innovation - The company emphasizes technology innovation and has made significant progress in core technologies, ensuring sustainable development of its main business[65]. - The integration of AI, IoT, and big data is transforming logistics operations, enabling real-time monitoring and intelligent scheduling[62]. - The company has developed several advanced systems, including an adaptive focus high-speed reading system based on 8K line array image sensors[39]. - The company is actively pursuing new product development, including a modular sorting device and a high-speed cross-belt sorting machine[71]. Operational Efficiency - The company plans to continue cost reduction and efficiency improvement strategies to adapt to market competition[23]. - The company has implemented an internal control system to improve risk management and operational standards[193]. - The company aims to optimize its production capacity and supply chain management to enhance operational efficiency and reduce manufacturing costs[178]. Risks and Challenges - The company faces risks from market demand fluctuations, particularly in the logistics equipment sector, which is heavily influenced by the performance of downstream industries[113]. - The company is at risk of core technology personnel turnover, which could adversely affect its future development in a highly competitive and technology-intensive industry[112]. - The company faced risks related to high accounts receivable and inventory levels, which could impact future performance[120][121]. Corporate Governance - The company is focused on enhancing its governance structure and ensuring independence from its controlling shareholders[195]. - The company has a diverse board of directors, including independent directors and a mix of male and female members[200]. - The company is committed to maintaining a transparent information disclosure process, ensuring timely and accurate communication with investors[192].

中科微至科技股份有限公司 2023 年度募集资金存放与实际使用情况专项报告的鉴证报告 KPMG Huazhen LLP 8th Floor. KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 Fax +86 (10) 8518 5111 Internet kpmg.com/cn 毕马威华振会计师事务所 (特殊普通合伙) 中国北京 东长安街1号 东方广场毕马威大楼8层 邮政编码:100738 电话 +86(10)8508 5000 传真 +86 (10) 8518 5111 网址 kpmg.com/cn 对中科微至科技股份有限公司 2023 年度募集资金存放与实际使用情况专项报告的鉴证报告 毕马威华振专字第 2401446 号 中科微至科技股份有限公司董事会： 我们接受委托，对后附的中科微至科技股份有限公司 (以下简称"中科微至") 2023 年度 募集资金存放与实际使用情况的专项报告(以下简称"专项报告")执行了合理保证的鉴证业 务，就专项报告是否在所有重大方面按 ...

关于中科微至科技股份有限公司 2023 年度营业收入扣除情况的专项报告 KPMG Huazhen LLP 8th Floor. KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 +86 (10) 8518 5111 Fax Internet kpmg.com/cn 毕马威华振会计师事务所 (特殊普通合伙) 中国北京 东长安街1号 东方广场毕马威大楼8层 邮政编码:100738 电话 +86 (10) 8508 5000 传真 +86 (10) 8518 5111 网址 kpmg.com/cn 关于中科微至科技股份有限公司 2023 年度营业收入扣除情况的专项报告 毕马威华振专字第 2401445 号 中科微至科技股份有限公司董事会: 我们接受委托,按照中国注册会计师审计准则审计了中科微至科技股份有限公司(以下简 称 "中科微至"）2023 年度的财务报表，包括 2023 年 12 月 31 日的合并及母公司资产负债 表，2023 年度的合并及母公司利润表、合并及母 ...

于 2023 年 12 月 31 日内部控制审计报告 中科微至科技股份有限公司 . KPMG Huazhen LLP 8th Floor, KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 Fax +86 (10) 8518 5111 Internet kpmg.com/cn 毕马威华振会计师事务所 (特殊普通合伙) 中国北京 东长安街1号 东方广场毕马威大楼8层 邮政编码 : 100738 电话 +86 (10) 8508 5000 传真 +86 (10) 8518 5111 网址 kpmg.com/cn 内部控制审计报告 毕马威华振审字第 2406720 号 中科微至科技股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我们审计了中 科微至科技股份有限公司（以下简称"中科微至"）2023 年 12 月 31 日的财务报告内部控制的有 效性。 一、 企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》 ...

证券代码：688211 证券简称：中科微至 公告编号：2024-011 中科微至科技股份有限公司 关于使用暂时闲置自有资金进行委托理财的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 金进行委托理财，提高闲置的资金的使用效率，增加公司收益。 （二）投资金额 重要内容提示： 投资种类：安全性高、流动性好、保本型的低风险理财产品。 投资金额：中科微至科技股份有限公司（以下简称"公司"）及控股子公 司 2024 年度理财产品额度最高不超过人民币 5 亿元。理财期限为自本次董事会 审议通过之日起一年，或至关于 2025 年度预计使用自有资金进行委托理财相关 决议通过之日止（以孰早者为准）。在上述额度和期限范围内，资金可循环投资、 滚动使用。 已履行及拟履行的审议程序：公司于 2024 年 4 月 20 日召开了第二届董 事会第九次会议、第二届监事会第七次会议，审议通过了《关于使用暂时闲置自 有资金进行委托理财的议案》，并授权公司总经理或其授权人办理相关事项。该 事项在董事会审批权限范围内，无需提交公司股东大会审议。 特别风险 ...

证券代码：688211 证券简称：中科微至 公告编号：2024-016 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 2023 年年度股东大会 召开日期时间：2024 年 5 月 13 日 14 点 00 分 中科微至科技股份有限公司 （一） 股东大会类型和届次 关于召开 2023 年年度股东大会的通知 召开地点：中科微至科技股份有限公司 109 会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 2024 年 5 月 13 日 至 2024 年 5 月 13 日 股东大会召开日期：2024年5月13日 本次股东大会涉及每一特别表决权股份享有的表决权数量应当与每一 普通股份的表决权数量相同的议案 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间 ...